rs772393451
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 12P and 4B. PP3_StrongPP5_Very_StrongBS2
The NM_005912.3(MC4R):c.749T>A(p.Leu250Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,614,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005912.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC4R | NM_005912.3 | c.749T>A | p.Leu250Gln | missense_variant | 1/1 | ENST00000299766.5 | NP_005903.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC4R | ENST00000299766.5 | c.749T>A | p.Leu250Gln | missense_variant | 1/1 | NM_005912.3 | ENSP00000299766 | P1 | ||
ENST00000658928.1 | n.156+42256A>T | intron_variant, non_coding_transcript_variant | ||||||||
ENST00000650201.1 | n.113+42256A>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251338Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135846
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727248
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74388
ClinVar
Submissions by phenotype
Obesity Pathogenic:2
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 22, 2020 | The p.Leu250Gln variant in MC4R has been reported in 3 individuals (including 1 European individual) with Obesity (PMID: 10903341, 16507637, 18559663), and has been identified in 0.002891% (1/34586) of Latino chromosomes and 0.002640% (3/113656) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs772393451). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a carrier frequency. Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. This variant has also been reported as a VUS and a likely pathogenic variant in ClinVar (Variation ID: 549551). In vitro functional studies provide some evidence that the p.Leu250Gln variant may impact cell membrane expression and constitutively activate the protein receptor (PMID: 16611215, 23791567, 12499395, 16507637, 12690102). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In vitro functional studies also provide some evidence that multiple, unique missense variants at the same position impact the protein and that this position is important for protein function (PMID: 16611215). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PS3_Moderate, PM2_Supporting, PP3, PS4_Supporting, PM5_Supporting (Richards 2015). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | Mar 10, 2017 | This c.749T>A (p.Leu250Gln) has previously been reported in multiple patients presenting with obesity [PMID 10903341, 16507637, 18559663, 12690102]. Functional assays showed that the receptor displayed high constitutive activity [PMID 12690102, 16611215, 16507637, 23791567]. However, cell surface expression level of the p.Leu250Gln mutant was decreased by about half of wild type [PMID 12690102, 16507637]. Thus the mechanism of pathogenicity of this variant in unclear at this time. This variant is conserved in mammals. This variant has been observed in one heterozygous individual from the ExAC database (http://exac.broadinstitute.org/variant/18-58038834-A-T). While not validated for clinical use, the computer-based algorithms predict this p.Leu250Gln change to be deleterious. It is thus interpreted as a likely pathogenic variant. - |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Oct 19, 2021 | - - |
MC4R-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 30, 2024 | The MC4R c.749T>A variant is predicted to result in the amino acid substitution p.Leu250Gln. This variant has been reported in individuals with obesity (Vaisse et al. 2000. PubMed ID: 10903341; Nijenhuis et al. 2003. PubMed ID: 12690102; Lubrano-Berthelier et al. 2006. PubMed ID: 16507637). Functional studies indicate this variant alters membrane expression and leads to high constitutive activity (Vaisse et al. 2000. PubMed ID: 10903341; Nijenhuis et al. 2003. PubMed ID: 12690102; Lubrano-Berthelier et al. 2006. PubMed ID: 16507637; Proneth et al. 2006. PubMed ID: 16611215; Xiang et al. 2006. PubMed ID: 16752916). This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD and has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from likely pathogenic to uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/549551/). Taken together, we interpret this variant as likely pathogenic. - |
Monogenic diabetes Uncertain:1
Uncertain significance, flagged submission | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Feb 10, 2017 | ACMG Criteria:PP3 (8 predictors), BP4 (3 predictors) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at